Evidence map›Paper›PMID 35829664›Full record

ArticleBritish journal of haematology2022

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

Chiara Favini, Donatella Talotta, Mohammad Almasri, Annalisa Andorno, Silvia Rasi, Ramesh Adhinaveni, Sreekar Kogila, Bassel Awikeh, Mattia Schipani, Paola Boggione and 11 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Treatment of Richter's Transformation with Novel Therapies.Current hematologic malignancy reports · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Chiara FaviniDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Donatella TalottaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Mohammad AlmasriDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Annalisa AndornoDivision of Pathology, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Silvia RasiDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Ramesh AdhinaveniDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Sreekar KogilaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Bassel AwikehDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Mattia SchipaniDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Paola BoggioneDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Samir MouhssineDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Joseph GhanejDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Wael Al EssaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Abdurraouf Mokhtar MahmoudDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Riccardo DondolinDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Nariman AlessaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Gloria Margiotta CasaluciDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Renzo BoldoriniDivision of Pathology, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Valter GatteiClinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Riccardo MoiaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.ORCID 0000-0001-7393-1138
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITCentro di Riferimento Oncologico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Richter syndrome (RS) is mostly due to the direct transformation of the chronic lymphocytic leukaemia (CLL) clone, as documented by the same immunoglobulin heavy-chain variable region (IGHV) rearrangement in both CLL and RS cells. In rare cases characterized by a better outcome, the RS clone harbours a different IGHV rearrangement compared to the CLL phase. We investigated the CLL phase of clonally unrelated RS to test whether the RS clone was already identifiable prior to clinicopathologic transformation, albeit undetectable by conventional approaches. CLL cells of eight patients with unrelated RS were subjected to an ultra-deep next-generation sequencing (NGS) approach with a sensitivity of 10

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseChromosome AberrationsHumansImmunoglobulin Variable RegionMutationImmunoglobulin Variable RegionCAPP-Seqdisease disseminationNGS IGHV analysisRichter syndrome

Identifiers

PMID35829664
PMCPMC9543999
OpenAlexW4285392978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.